These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19761435)

  • 1. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
    de Souza AP; Bonorino C
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
    Gross S; Walden P
    Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of antitumor immune responses by hematopoietic cytokines.
    Waller EK; Ernstoff MS
    Cancer; 2003 Apr; 97(7):1797-809. PubMed ID: 12655538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy.
    Wojtowicz-Praga S
    J Immunother; 1997 May; 20(3):165-77. PubMed ID: 9181454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.
    Neeson P; Paterson Y
    Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors and the danger model.
    Kowalczyk DW
    Acta Biochim Pol; 2002; 49(2):295-302. PubMed ID: 12362970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive networks in the tumour environment and their therapeutic relevance.
    Zou W
    Nat Rev Cancer; 2005 Apr; 5(4):263-74. PubMed ID: 15776005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in cancer immunotherapy.
    van den Broek M; von Boehmer L; Knuth A
    Dig Dis; 2010; 28(1):51-6. PubMed ID: 20460890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
    Stewart TJ; Smyth MJ
    Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
    Salih HR; Nüssler V
    Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current immunotherapeutic strategies in pancreatic cancer.
    Plate JM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):919-43, xi. PubMed ID: 18022552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor-draining lymph node as an immune-privileged site.
    Munn DH; Mellor AL
    Immunol Rev; 2006 Oct; 213():146-58. PubMed ID: 16972902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
    Chatterjee M; Draghici S; Tainsky MA
    Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.